Literature DB >> 11502809

Effect of short-term fasting on free and bound leptin concentrations in lean and obese women.

M Landt1, J F Horowitz, S W Coppack, S Klein.   

Abstract

Plasma leptin exists in protein-bound and free forms, which may affect its hormonal bioactivity. Therefore, the relationship between bound and free leptin may be particularly important during physiological conditions that cause rapid alterations in total plasma leptin concentration, such as fasting. The purpose of this study was to evaluate the effect of short-term fasting on bound and free plasma leptin concentrations and leptin binding capacity (a measure of plasma leptin-binding protein content) in lean and obese women. Six lean (body mass index, 21 +/- 1 kg/m2) and 6 abdominally obese (BMI, 36 +/- 1 kg/m2) women were studied after 14 h and 22 h of fasting. Although total plasma leptin concentration was more than 6-fold greater in obese (45.4 +/- 7.6 microg/liter) compared with lean (7.4 +/- 1.0 microg/liter) women at 14 h of fasting (P < 0.05), the percentage of leptin in the bound form was greater in lean than obese subjects (29 +/- 2% vs. 12 +/- 3%; P < 0.05). Arterial total, free, and bound plasma leptin concentrations all declined between 14 h and 22 h of fasting in both lean and obese groups, but the relative decline of these fractions was greater in lean (36 +/- 4%, 60 +/- 9%, and 51 +/- 13%, respectively) than in obese (19 +/- 5%, 21 +/- 8%, and 12 +/- 7%, respectively) subjects (all P < 0.05). In contrast, leptin binding capacity was unchanged. The percentage of total plasma leptin present in bound form was constant between 14 h and 22 h of fasting in lean subjects and increased slightly but significantly in obese subjects. These data demonstrate that both free and bound fractions of leptin in plasma decrease quickly in response to energy restriction, but the decline is blunted in abdominally obese compared with lean women. In addition, the equilibrium between bound and free leptin fractions is maintained during brief fasting and is not regulated by leptin binding capacity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502809     DOI: 10.1210/jcem.86.8.7771

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN).

Authors:  Unab I Khan; Dan Wang; Maryfran R Sowers; Peter Mancuso; Susan A Everson-Rose; Philipp E Scherer; Rachel P Wildman
Journal:  Metabolism       Date:  2012-03-22       Impact factor: 8.694

2.  The Role of Leptin in Maintaining Plasma Glucose During Starvation.

Authors:  Rachel J Perry; Gerald I Shulman
Journal:  Postdoc J       Date:  2018-03

3.  Leptin-reactive antibodies are distinctly correlated with body composition parameters and metabolic risk indexes in children and adolescents.

Authors:  Rafael Vázquez-Solórzano; Elia Valdés-Miramontes; Mildren Porchas-Quijada; Mayra Enciso-Ramírez; Guadalupe A Contreras-Mata; Alma Gabriela Martínez-Moreno; Lourdes Barajas-García; Astrid Selene Espinoza-García; Zyanya Reyes-Castillo
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

4.  Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women's Health Across the Nation.

Authors:  Rebecca C Thurston; Yuefang Chang; Peter Mancuso; Karen A Matthews
Journal:  Fertil Steril       Date:  2013-06-10       Impact factor: 7.329

5.  Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance?

Authors:  Tommy Jönsson; Stefan Olsson; Bo Ahrén; Thorkild C Bøg-Hansen; Anita Dole; Staffan Lindeberg
Journal:  BMC Endocr Disord       Date:  2005-12-10       Impact factor: 2.763

6.  Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes.

Authors:  Kirsten Katrine Lindegaard; Nils Bruun Jorgensen; Rasmus Just; Peter Mh Heegaard; Sten Madsbad
Journal:  Diabetol Metab Syndr       Date:  2015-02-24       Impact factor: 3.320

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.